Review Article
Volume 8 Issue 8 - 2021
Nicotine Addiction and Smoking Cessation Programs in Private Practice and the Public Health Sector: A Comprehensive and Practical Review of How Populations Become Addicted to Nicotine and Programs for Tobacco Smoking Cessation
Nicholas A Kerna1,2*, John V Flores3,4, Hilary M Holets3,4, Abdullah Hafid5, Kevin D Pruitt6,7, ND Victor Carsrud8, Uzoamaka Nwokorie9, Joseph Anderson II10, Sahalia Rashid11 and Zeyad Albadri12
1SMC–Medical Research, Thailand
2First InterHealth Group, Thailand
3Beverly Hills Wellness Surgical Institute, USA
4Orange Partners Surgicenter, USA
5Wayne State University, USA
6Kemet Medical Consultants, USA
7PBJ Medical Associates, USA
8Lakeline Wellness Center, USA
9University of Washington, USA
10International Institute of Original Medicine, USA
11All Saints University School of Medicine, Dominica
12Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linkoping University, Linkoping, Sweden
*Corresponding Author: Nicholas A Kerna, (mailing address) POB47 Phatphong, Suriwongse Road, Bangkok, Thailand 10500.
Received: July 11, 2021; Published: July 31, 2021




Abstract

Nicotine in tobacco increases dopamine release, which boosts mood and provides a sense of stress release. However, tobacco's availability in numerous forms for consumption makes it difficult to control addiction—even after programs promoting the awareness of its harm to people, society, and the economy. The influence of family and friends is considered a common reason for starting a nicotine habit. Thus, even though tobacco addiction is a global problem, it is challenging to tobacco's notable economic advantages with public health concerns. The following research provides a comprehensive overview of tobacco addiction, including its history, the current situation, its impact on society and the economy, international guidelines, in-clinic, public health smoking cessation regimes and programs, and government legislation to reduce tobacco use in the general population.

Keywords: Addiction; Cancer; Cessation Programs; Nicotine; Public Health; Tobacco

References

  1. Laniado-Laborín R. “Smoking and Chronic Obstructive Pulmonary Disease (COPD). Parallel Epidemics of the 21st Century”. International Journal of Environmental Research and Public Health1 (2009): 209-224. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672326/
  2. Jha P and Chaloupka FJ. “Curbing the Epidemic: Governments and the Economics of Tobacco Control. Washington DC: The World Bank (1999). https://tobaccocontrol.bmj.com/content/8/2/196
  3. Warren CW., et al. “Tobacco use in youth: a surveillance report from the Global Youth Tobacco Survey Project”. Bulle-tin of World Health Organization 78 (2000): 868-876. https://pubmed.ncbi.nlm.nih.gov/10994259/
  4. Britannica Encyclopedia, A social and cultural history of smoking (2021).
  5. Hughes JR. “Nicotine-related disorders”. In: Sadock BJ, Sadock VI, editor. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 7. Philadelphia, Lippincott: Williams and Wilkins (2000).
  6. Gupta VM and Sen P. “Tobacco: the addictive slow poison (editorial)”. Indian Journal of Public Health 45 (2001): 75-81. https://pubmed.ncbi.nlm.nih.gov/11917325/
  7. Greden JF. “Caffeine and tobacco dependence”. In: Kaplan HI, Freedman AM, Sadock BJ, editor. Comprehensive Textbook of Psychiatry. 3. Baltimore: Williams and Wilkins (1980).
  8. Mishra S and Mishra MB. “Tobacco: Its historical, cultural, oral, and periodontal health association”. Journal of International Society of Preventive and Community Dentistry1 (2013): 12-18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894096/
  9. Luthra U., et al. “Tobacco control in India: Problems and solutions”. In: Gupta PC, Hamner JE, Murti PR (eds). Control of tobac-co-related cancers and other diseases. International Symposium, 1990. Bombay: Oxford University Press (1992): 2417.
  10. Devine TM Jordan Goodman. “Tobacco in history: The Cultures of dependence”. Scottish Economic and Social History1 (1995). https://www.routledge.com/Tobacco-in-History-The-Cultures-of-Dependence/Goodman/p/book/9780415116695
  11. Chattopadhayya A. “Harmful effects of tobacco noticed in history”. Bulletin of Insti-tute of History of Medicine, Hyderabad 23 (1993): 53-58. https://pubmed.ncbi.nlm.nih.gov/11639383/
  12. Gajalakshmi V and Kanimozhi CV. “A Survey of 24,000 Students Aged 13–15 Years in In-dia: Global Youth Tobacco Survey 2006 and 2009”. Tobacco Use Insights 3 (2010): 23-33. https://journals.sagepub.com/doi/full/10.1177/1179173X1000300001
  13. Global Adult Tobacco Survey (GATS) India: 2009-2010 (2021).
  14. Fact Sheet India: 2009–2010. Ministry of Health and Family Welfare, Gov-ernment of India; 2010 (2021).
  15. Ahmed NU., et al. “Prevalence and correlates of initiation of smoking behavior among preteen black and white children”. Journal of the National Medical Association 96 (2004): 200-208. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2594973/
  16. Arrazola RA., et al. “Tobacco use among middle and high school students-United States, 2013”. Morbidity and Mortality Weekly Report 63 (2014): 1021-1026. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6345a2.htm
  17. Hammond D. “Smoking behaviour among young adults: beyond youth prevention”. Tobacco Control 14 (2005): 181-185. https://pubmed.ncbi.nlm.nih.gov/15923468/
  18. Ashley DL., et al. “Tobacco-specific nitrosamines in tobacco from US brand and non-U.S. brand cigarettes”. Nicotine and Tobacco Research3 (2003): 323-331. https://pubmed.ncbi.nlm.nih.gov/12791527/
  19. Gupta S., et al. “Relationship between the type of smoke-less tobacco and risk of cancer: A systematic review”. Indian Journal of Medical Research1 (2018): 57-76. https://pubmed.ncbi.nlm.nih.gov/30264755/
  20. Leading cause of death, illness, and impoverishment (2021). https://www.who.int/news-room/fact-sheets/detail/tobacco
  21. The MPOWER package, warning about the dangers of tobacco. Geneva; WHO Report on The Global Tobacco Epidemic, 2011 (2021).
  22. Xu X., et al. “Annual healthcare spend-ing attributable to cigarette smoking: an update”. American Journal of Preventive Medicine 3 (2015): 326-333. https://pubmed.ncbi.nlm.nih.gov/25498551/
  23. A global epidemic of addiction and disease. Tobacco: deadly in any form or disguise”. WHO Tobacco Free Initiative (2021). https://www.who.int/health-topics/tobacco#tab=tab_1
  24. Jindal SK., et al. “A multicentric study on the epidemiology of chronic obstructive pulmonary disease and its relationship with to-bacco smoking and environmental tobacco smoke exposure”. The Indian Journal of Chest Diseases and Allied Sciences1 (2006): 23-29. https://pubmed.ncbi.nlm.nih.gov/16482948/
  25. WHO Report on The Global Tobacco Epidemic, 2009. Implementing smoke-free environments”. Fresh and Alive Mpower (2021). https://www.who.int/teams/health-promotion/tobacco-control/who-report-on-the-global-tobacco-epidemic-2019
  26. Goud ML., et al. “Epidemiolog-ical Correlates between Consumption of Indian Chewing Tobacco and Oral Cancer”. European Journal of Epidemiology 2 (1990): 219-222. https://pubmed.ncbi.nlm.nih.gov/2361546/
  27. Vuolo M and Staff J. “Parent and Child Cigarette Use: A Longitudinal, Multigenerational Study”. Pediatrics 3 (2013): e568-e577. https://pediatrics.aappublications.org/content/132/3/e568
  28. Dwivedi S., et al. “The intergenerational transmission of tobacco habit: Role of parents and the family”. Journal of Family Medicine and Primary Care 2 (2016): 373-377. https://www.researchgate.net/publication/309294978_The_intergenerational_transmission_of_tobacco_habit_Role_of_parents_and_the_family
  29. Leonardi-Bee J., et al. “Exposure to parental and sibling smoking and the risk of smoking uptake in childhood and adolescence: a systematic review and meta-analysis”. Thorax 66 (2011): 847e855. https://pubmed.ncbi.nlm.nih.gov/21325144/
  30. Zickler P. “Early nicotine initiation increases the severity of addiction, vulnerability to some effects of cocaine”. National Institute on Drug Abuse 19 (2004): 8. https://archives.drugabuse.gov/news-events/nida-notes/2004/07/early-nicotine-initiation-increases-severity-addiction-vulnerability-to-some-effects-cocaine
  31. O'Callaghan FV., et al. “Prediction of adolescent smoking from family and social risk factors at 5 years, and maternal smok-ing in pregnancy and at 5 and 14 years”. Addiction 101 (2006): 282-290. https://pubmed.ncbi.nlm.nih.gov/16445557/
  32. Zhou FM., et al. “Endogenous nicotinic cholinergic activity regulates do-pamine release in the striatum”. Nature Neuroscience12 (2001): 1224-1229. https://www.nature.com/articles/nn769
  33. Choi D and Ota S S. “Does cigarette smoking relieve stress? Evidence from the event-related potential (ERP)”. International Journal of Psychophysiology3 (2015): 470-476. https://www.researchgate.net/publication/283115082_Does_cigarette_smoking_relieve_stress_Evidence_from_the_event-related_potential_ERP
  34. Lawless MH., et al. “Perceived stress and smoking-related behaviors and symptomatology in male and female smokers”. Addict Be-hav 51 (2015): 80-83. https://pubmed.ncbi.nlm.nih.gov/26240941/
  35. Brownell KD. “Dieting and the search for the perfect body: Where physiology and culture collide”. Behavior Therapy 22 (1991): 1-12. https://www.sciencedirect.com/science/article/abs/pii/S0005789405802394
  36. S Chapman. “Curbing the epidemic: governments and the economics of tobacco con-trol”. BMJ 7228 (2000): 192. https://pubmed.ncbi.nlm.nih.gov/10634758/
  37. Statista, Tobacco duty tax receipts in the United Kingdom from 2000/01 to 2020/21 (2021).
  38. Gale F. “Tobacco dollars and jobs. Tobacco Situation and Outlook. US Department of Agriculture, Economic Research Service, TBS-239 (1997): 37-34.
  39. Gale F. “Economic structure of tobacco-growing regions. Tobacco Situation and Out-look. US Department of Agriculture, Economic Research Service, TBS-241 (1998): 40-47.
  40. WHO Framework Convention on Tobacco Control. World Health Organiza-tion (2003). http://apps.who.int/iris/bitstream/handle/10665/42811/9241591013.pdf;jsessionid=22932D45501661498DF4AF78F7AF7D20?sequence=1
  41. Warner KE., et al. “The medical costs of smoking in the United States: estimates, their validity, and their implications”. Tobacco Control 8 (1999): 290-300. https://pubmed.ncbi.nlm.nih.gov/10599574/
  42. The MPOWER package, warning about the dangers of tobacco. Geneva; 2011”. WHO Report on The Global Tobacco Epidemic (2021). https://apps.who.int/tobacco/global_report/2011/en/index.html
  43. US Army Medical Command and The Veterans Health Administration. VA/DoD Clinical Practice Guideline for the management of Tobacco Use (2004).
  44. WHO, Report on tobacco control in India (2021).
  45. Peto R. “Smoking and death: The past 40 years and the next 40”. BMJ 309 (1994): 9379. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2541135/
  46. Chaloupka FJ and Warner KE. “The economics of smoking”. In: Newhouse JP, Cuyler AJ, editors. The handbook of health economics. New York: North-Holland (2000). https://www.nber.org/papers/w7047
  47. Jha P., et al. “The taxation of tobacco products”. In: Jha P, Chaloupka FJ, editors. Tobacco control in developing coun-tries. Oxford: Oxford University Press (2000): 237-272. https://www.researchgate.net/publication/252543580_The_taxation_of_tobacco_products
  48. Hu TW and Mao Z. “Effects of cigarette tax on cigarette consumption and the Chinese economy”. Tobacco Control2 (2002): 105-108. https://tobaccocontrol.bmj.com/content/11/2/105
  49. John RM., et al. “The Economics of Tobacco and Tobacco Taxation in India. Paris: International Union Against Tuberculosis and Lung Disease (2010). https://www.tobaccofreekids.org/assets/global/pdfs/en/India_tobacco_taxes_report_en.pdf
  50. Drovandi A., et al. “Australian School Student Percep-tions of Effective Anti-tobacco Health Warnings”. Front Public Health 6 (2018): 297. https://www.researchgate.net/publication/328341467_Australian_School_Student_Perceptions_of_Effective_Anti-tobacco_Health_Warnings
  51. The United States Centers for Disease Control and Prevention, Tobacco Control Programs (2021).
  52. UK. Policy paper. Smoke-free generation: tobacco control plan for England (2021). https://www.gov.uk/government/publications/towards-a-smoke-free-generation-tobacco-control-plan-for-england
  53. US FDA, Family Smoking Prevention and Tobacco Control Act - An Overview (2021). https://www.fda.gov/tobacco-products/rules-regulations-and-guidance/family-smoking-prevention-and-tobacco-control-act-overview
  54. Lairson DR., et al. “Screening for patients with alcohol problems: severity of patients identified by the CAGE”. The Journal of Drug Education 4 (1992): 337-352. https://pubmed.ncbi.nlm.nih.gov/1484331/
  55. Mishra GA., et al. “Call centre employees and tobacco dependence: making a difference”. Indian Journal of Cancer 1 (2010): 43-52. https://pubmed.ncbi.nlm.nih.gov/20622414/
  56. Murthy P and Saddichha S. “Tobacco cessation services in India: recent developments and the need for expansion”. Indian Journal of Cancer 1 (2010): 69-74. https://pubmed.ncbi.nlm.nih.gov/20622418/
  57. American Psychiatric Association. Diagnostic and statistical manual of mental dis-orders: DSM 5”. American Psychiatric Association; Washington (2013).
  58. Heishman SJ., et al. “Meta-analysis of the acute effects of nico-tine and smoking on human performance”. Psychopharmacology4 (2010): 453-469. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151730/
  59. Heart attack, Medline plus (2021).
  60. West R., et al. “Impact of UK policy initiatives on use of medicines to aid smoking cessation”. Tobacco Control3 (2005): 166-171. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1748027/
  61. Jiloha RC. “Pharmacotherapy of smoking cessation”. Indian Journal of Psychiatry1 (2014): 87-95. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927255/
  62. Nicotine Lozenge, Web Med (2021).
  63. Stead LF., et al. “Nicotine replacement therapy for smoking cessa-tion”. Cochrane Database of Systematic Reviews 11 (2012): CD000146. https://pubmed.ncbi.nlm.nih.gov/23152200/
  64. Glover ED., et al. “A com-parison of a nicotine sublingual tablet and placebo for smoking cessation”. Nicotine and Tobacco Research 4 (2002): 441-450. https://pubmed.ncbi.nlm.nih.gov/12521403/
  65. Tobacco Dependence Treatment Guidelines, National Tobacco Control Programme, Govt of India (2021). https://ntcp.nhp.gov.in/assets/document/Guideline-manuals/Tobacco-Dependence-Treatment-Guidelines.pdf
  66. Prochazka AV., et al. “A randomized trial of nortriptyline for smoking cessation”. Archives of Internal Medicine18 (1998): 2035-2039. https://pubmed.ncbi.nlm.nih.gov/9778204/
  67. Gourlay SG., et al. “Clonidine for smoking cessation”. Cochrane Database of Systematic Reviews 3 (2004): CD000058. https://pubmed.ncbi.nlm.nih.gov/15266422/
  68. Jain R., et al. “A Double-Blind Placebo-Controlled Randomized Trial of Varenicline for Smokeless Tobacco Dependence in India”. Nicotine and Tobacco Research1 (2014): 50-57. https://pubmed.ncbi.nlm.nih.gov/23946326/
  69. Tobacco Cessation Centre, NIMHANS. 2009. Starting tobacco cessation services (2021).
  70. Roche AM., et al. “Teaching smoking cessation skills to senior medical students: a block-randomized controlled trial of four different approaches”. Preventive Medicine3 (1996): 251-258. https://pubmed.ncbi.nlm.nih.gov/8781002/
  71. Fiore MC., et al. “Treating Tobacco Use and Dependence-2008 Update. Rockville, Md, Public Health Services, US Department of Health and Human Ser-vices (2008). https://www.ncbi.nlm.nih.gov/books/NBK63952/
  72. Myung S., et al. “Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis”. BJOG: An International Journal of Obstetrics and Gynaecology 119 (2012): 1029-1039. https://pubmed.ncbi.nlm.nih.gov/22780818/
Citation: Kerna NA, Flores JV, Holets HM, Hafid A, Carsrud NDV, Nwokorie U Anderson II, Rashid S, Albadri Z. “Nicotine Addiction and Smoking Cessation Programs in Private Practice and the Public Health Sector: A Comprehensive and Practical Review of How Populations Become Addicted to Nicotine and Programs for Tobacco Smoking Cessation”. EC Cardiology 8.8 (2021): 25-37.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 13, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.